Fielder Capital Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $467K | Buy |
2,516
+102
| +4% | +$18.9K | 0.12% | 109 |
|
|
2025
Q1 | $506K | Buy |
2,414
+32
| +1% | +$6.71K | 0.15% | 92 |
|
|
2024
Q4 | $423K | Buy |
2,382
+113
| +5% | +$20.1K | 0.13% | 112 |
|
|
2024
Q3 | $448K | Buy |
2,269
+14
| +0.6% | +$2.77K | 0.15% | 98 |
|
|
2024
Q2 | $387K | Buy |
2,255
+77
| +4% | +$13.2K | 0.15% | 95 |
|
|
2024
Q1 | $397K | Buy |
2,178
+12
| +0.6% | +$2.19K | 0.18% | 86 |
|
|
2023
Q4 | $336K | Buy |
+2,166
| New | +$336K | 0.2% | 86 |
|